About Qingdao Haier Biomedical Co., Ltd. Company

The company began with R&D, production and sales of biomedical cryogenic storage devices. It is a new species of IoT technology ecosystem based on the transformation of the Internet of Things. With the goal of optimal user experience, Haier Biotech provides IoT biotechnology solutions for blood safety scenarios, vaccination scenarios, biological sample bank scenarios, drug and reagent scenarios, etc., and links all stakeholders to create an IoT experience ecosystem where people, devices, and scenarios are interconnected, and drive the iterative evolution of technology. With the goal of creating the best user experience, the company targets life science users such as pharmaceutical and biological companies, university research institutions, etc., and medical and health care users such as hospitals, disease control, blood stations, and primary health care. It has formed two major segments of life science and medical innovation, providing comprehensive solutions for digital scenarios represented by smart laboratories, digital hospitals, smart public health, and smart blood use. The company's main products include cryogenic storage boxes, automated biological sample storage, fully automatic cell culture workstations, automated liquid nitrogen tanks, program coolers, aviation temperature-controlled containers, fully automatic freeze-dryers, biosafety cabinets, centrifuges, carbon dioxide incubators, high-pressure sterilizers, thermostatic drying boxes, biochemical incubators, environmental test chambers, artificial climate chambers, sterile isolators, hydrogen peroxide sterilizers, independent ventilation cages, controlled freeze-thaw systems, ultraviolet visible spectrophotometers, etc. Corporate honors: Second Prize for National Science and Technology Progress, Strategic Cooperation Contribution Award, Gazelle Enterprise, etc.